BELUDAVIMAB
UNII FM2MK5954W

Substance Identification & Data

This profile provides standardized clinical and technical data for Beludavimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) FM2MK5954W.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2423016-74-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

FM2MK5954W

CAS Registry Number

2423016-74-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

BELUDAVIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C182625

National Cancer Institute reference terminology for clinical and research data.

INN ID

11961

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

KL-48

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Beludavimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

BELUDAVIMAB

Common Names & Synonyms

BELUDAVIMAB [INN]

BELUDAVIMAB [USAN]

IMMUNOGLOBULIN G1 (246-ALANINE,340-LEUCINE,342-GLUTAMIC ACID,438-LEUCINE,444-SERINE), ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN RECEPTOR-BINDING DOMAIN) (HUMAN MONOCLONAL VIR-7832 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL VIR-7832 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) SPIKE (S) GLYCOPROTEIN, RECEPTOR BINDING DOMAIN (RBD)), HOMO SAPIENS MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN HOMO SAPIENS (1-457) (VH (HOMO SAPIENS IGHV1-18*01 (92.9%)-(IGHD)-IGHJ5*01 (92.9%), CDR-IMGT (8.8.20) (26-33.51-58.97-116)) (1-127)-HOMO SAPIENS IGHG1*01, G1M17,1, G1V12 CH2 A1.1, L115, E117, G1V24 CH3 L107, S114 (CH1 K120 (224) (128-225), HINGE 1-15 (226-240), CH2 G1.1>A (246), A115>L (340), I117>E (342) (241-350), CH3 D12 (366), L14 (368), M107>L (438), N114>S (444) (351-455), CHS (456-457)) (128-457)), (230-214')-DISULFIDE WITH KAPPA LIGHT CHAIN HOMO SAPIENS (1'-214') (V-KAPPA (HOMO SAPIENS IGKV3-20*01 (93.7%)-IGKJ4*01 (100%), CDR-IMGT (7.3.8) (27-33.51-53.90-97)) (1'-107')-HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (153), V101 (191) (108'-214')); DIMER (236-236'':239-239'')-BISDISULFIDE, PRODUCED IN A CHINESE HAMSTER OVARY (CHO)-K1 CELL LINE, GLYCOFORM ALFA

VIR 7832 [WHO-DD]